[1]徐娜,胡咏新,刘超.2022中欧和东欧专家共识《维生素D缺乏的预防、诊断和治疗的临床实践》解读:凝聚共识,规范诊治[J].国际内分泌代谢杂志,2023,43(04):357-360.[doi:10.3760/cma.j.cn121383-20221105-11013]
　Xu Na,Hu Yongxin,Liu Chao.2022 Central and Eastern European Expert Consensus Interpretation of Clinical Practice on Prevention, Diagnosis and Treatment of Vitamin D Deficiency: build consensus and standardize diagnosis and treatment[J].International Journal of Endocrinology and Metabolism,2023,43(04):357-360.[doi:10.3760/cma.j.cn121383-20221105-11013]
点击复制

2022中欧和东欧专家共识《维生素D缺乏的预防、诊断和治疗的临床实践》解读:凝聚共识,规范诊治()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
43
期数:
2023年04期
页码:
357-360
栏目:
指南与共识
出版日期:
2023-07-20

文章信息/Info

Title:
2022 Central and Eastern European Expert Consensus Interpretation of Clinical Practice on Prevention, Diagnosis and Treatment of Vitamin D Deficiency: build consensus and standardize diagnosis and treatment
作者:
徐娜1; 胡咏新2; 刘超2
1高邮市中西医结合医院内分泌科,扬州 225600; 2南京中医药大学附属中西医结合医院内分泌科,南京 210028
Author(s):
Xu Na1;  Hu Yongxin2;  Liu Chao2
1Department of Endocrinology, Gaoyou Hospital of Integrated Traditional Chinese and Western Medicine, Yangzhou 225600, China; 2Department of Endocrinology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Traditional Chinese Medicine, Nanjing 210028, China
关键词:
维生素D缺乏;  预防;  诊断;  治疗
Keywords:
Vitamin D deficiency;  Prevention;  Diagnosis;  Treatment
DOI:
10.3760/cma.j.cn121383-20221105-11013
摘要:
维生素D缺乏是全球范围内流行的公共卫生难题,日益受到学术界和公众的广泛关注。2022年中欧和东欧专家共识发布了《维生素D缺乏的预防、诊断和治疗的临床实践》,为改善这一现状提供了详尽的临床指导。熟悉该临床实践中的相关内容,对维生素D缺乏的规范诊疗有着非常重要的临床意义。
Abstract:
Vitamin D deficiency is a global public health problem, which has been paid more and more attention. In 2022, the Central and Eastern European Expert Committee issued the Clinical Practice in the Prevention, Diagnosis and Treatment of Vitamin D Deficiency, which provides detailed clinical guidance for improving this situation. It is of great clinical significance for the standardized diagnosis and treatment of vitamin D deficiency to be familiar with the relevant important contents in the clinical practice.

参考文献/References:

[1] Pludowski P,Takacs I,Boyanov M,et al.Clinical practice in the prevention,diagnosis and treatment of vitamin D deficiency:A Central and Eastern European Expert Consensus Statement[J].Nutrients,2022,14(7):1483.DOI:10.3390/nu14071483.
[2] Cashman KD,Dowling KG,Sˇkrabáková Z,et al.Vitamin D deficiency in Europe:pandemic?[J].Am J Clin Nutr,2016,103(4),1033-1044.DOI:10.3945/ajcn.115.120873.
[3] Lips P,Cashman KD,Lamberg-Allardt C,et al.Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency:a position statement of the European Calcified Tissue Society[J].Eur J Endocrinol,2019,180(4):P23-P54.DOI:10.1530/EJE-18-0736.
[4] Pilz S,Trummer C,Pandis M,et al.Vitamin D:current guidelines and future outlook[J].Anticancer Res,2018,38(2):1145-1151.DOI:10.21873/anticanres.
[5] Bacha DS,Rahme M,Al-Shaar L,et al.Vitamin D3 dose requirement that raises 25-hydroxyvitamin D to desirable level in overweight and obese elderly[J]. J Clin Endocrinol Metab,2021,106(9):e3644-e3654.DOI:10.1210/clinem/dgab296.
[6] Ramasamy I.Vitamin D metabolism and guidelines for vitamin D supplementation[J].Clin Biochem Rev,2020,41(3):103-126.DOI:10.33176/AACB-20-00006.
[7] Mazess RB,Bischoff-Ferrari HA,Dawson-Hughes B.Vitamin D:bolus is bogus-a narrative review[J].JBMR Plus,2021,5(12),e10567.DOI:10.1002/jbm4.10567.
[8] Rothen JP,Rutishauser J,Walter PN,et al.Oral intermittent vitamin D substitution:influence of pharmaceutical form and dosage frequency on medication adherence:a randomized clinical trial[J].BMC Pharmacol Toxicol,2020,21(1):51.DOI:10.1186/s40360-020-00430-5.
[9] Bilezikian JP,Formenti AM,Adler RA,et al.Vitamin D:dosing,levels,form,and route of administration:does one approach fit all?[J].Rev Endocr Metab Disord,2021,22(4):1201-1218.DOI:10.1007/s11154-021-09693-7.
[10] Heaney RP,Armas LA.Quantifying the vitamin D economy[J].Nutr Rev,2015,73(1):51-67.DOI:10.1093/nutrit/nuu004.
[11] Nielsen OH,Hansen TI,Gubatan JM,et al.Managing vitamin D deficiency in inflammatory bowel disease[J].Frontline Gastroenterol,2019,10(4):394-400.DOI:10.1136/flgastro-2018-101055.
[12] Sosa Henríquez M,Gómez de Tejada Romero MJ.Cholecalciferol or calcifediol in the management of vitamin D deficiency[J].Nutrients,2020,12(6):1617.DOI:10.3390/nu12061617.
[13] Vieth R.Vitamin D supplementation:cholecalciferol,calcifediol,and calcitriol[J].Eur J Clin Nutr,2020,74(11):1493-1497.DOI:10.1038/s41430-020-0697-1.
[14] Bouillon R,Manousaki D,Rosen C,et al.The health effects of vitamin D supplementation:evidence from human studies[J].Nat Rev Endocrinol,2022,18(2):96-110.DOI:10.1038/s41574-021-00593-z.
[15] Carmel AS,Bockman RS.Vitamin D and bisphosphonate response[J].Osteoporos Int,2014,25(8):2155.DOI:10.1007/s00198-014-2711-8.
[16] Autier P,Boniol M,Pizot C,et al.Vitamin D status and ill health:a systematic review[J].Lancet Diabetes Endocrinol,2014,2(1):76-89.DOI:10.1016/S2213-8587(13)70165-7.

相似文献/References:

[1]郝帅,郭丽婷,高志红.2型糖尿病患者维生素D缺乏的调查分析[J].国际内分泌代谢杂志,2014,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2014.03.003]
　Hao Shuai,Guo Liting,Gao Zhihong..Ａnalysis of vitamin D deficiency in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2014,(04):153.[doi:10.3760/cma.j.issn.1673-4157.2014.03.003]
[2]Eberhard Standl*,Michael J Theodorakis,Michael Erbach,等.阿卡波糖减少心血管疾病风险的潜能[J].国际内分泌代谢杂志,2016,36(01):32.[doi:10.3760/cma.j.issn.1673-4157.2016.01.008]
[3]徐俊,许樟荣.国际糖尿病足工作组糖尿病足溃疡预防及创面干预(2019年版)指南解读[J].国际内分泌代谢杂志,2021,41(06):661.[doi:10.3760/cma.j.cn121383-20210112-01031]
　Xu Jun,Xu Zhangrong..[J].International Journal of Endocrinology and Metabolism,2021,41(04):661.[doi:10.3760/cma.j.cn121383-20210112-01031]
[4]齐晓洁,苏恒.1型糖尿病的二级预防临床研究进展[J].国际内分泌代谢杂志,2022,42(03):187.[doi:10.3760/cma.j.cn121383-20210129-01088]
　Qi Xiaojie,Su Heng..Progress in secondary prevention of type 1 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2022,42(04):187.[doi:10.3760/cma.j.cn121383-20210129-01088]

备注/Memo

备注/Memo:
基金项目:江苏省干部保健局科技项目(BJ18030); 江苏省中医药管理局科技项目(MS2021023)
通信作者：胡咏新，Email：hyx497@163.com
更新日期/Last Update: 2023-08-15